BioCryst Pharmaceuticals announced that it has signed a licensing agreement with the Irish subsidiary of Neopharmed Gentili regarding the rights to the hereditary angioedema treatment drug Navenibart in Europe.
Show original
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
This collaboration marks an important step forward for BioCryst in expanding the global market presence of its core products.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now！
You may also like
Sui DeFi Protocol AlphaFi Winds Down After Oracle Debt Issue
CoinCryptoNewz•2026/09/27 00:33
CME Group Launches Micro Futures for SUI and Sui Ecosystem DeFi
Cointime•2026/09/26 23:59
SEC Crypto Asset Rules Clarify Token Buybacks and Upgrades
CoinCryptoNewz•2026/09/26 21:06
Crypto prices
More
Bitcoin
BTC
$84,376.13
+0.47%
Ethereum
ETH
$2,694.38
+0.20%
Tether USDt
USDT
$0.9997
-0.01%
BNB
BNB
$770.81
-0.42%
XRP
XRP
$1.51
-2.91%
USDC
USDC
$0.9998
-0.00%
Solana
SOL
$120.39
-0.18%
TRON
TRX
$0.3330
-1.36%
Zcash
ZEC
$1,638.65
+6.74%
Hyperliquid
HYPE
$92.75
+0.76%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now